{"id":3819,"date":"2021-11-19T19:16:53","date_gmt":"2021-11-19T19:16:53","guid":{"rendered":"https:\/\/www.merck.ca\/en\/?page_id=3819"},"modified":"2026-05-21T15:56:05","modified_gmt":"2026-05-21T15:56:05","slug":"disclosure-report","status":"publish","type":"page","link":"https:\/\/www.merck.ca\/en\/disclosure-report\/","title":{"rendered":"Transparency & Disclosure Report"},"content":{"rendered":"\n
\n
\n
\n
\n \n\t\n\n\n\n\t\"Two\n<\/picture> <\/div>\n
\n <\/div>\n <\/div>\n\n
\n \n

Transparency & Disclosure<\/h1>\n \n

We aspire to be transparent about how we operate to earn the trust and confidence of our customers and other stakeholders.<\/p>\n<\/div>\n \n <\/div>\n <\/div>\n\n \n<\/div>\n\n\n\n

Voluntary Disclosure of Payments to Healthcare
Professionals and Healthcare Organizations<\/h3>\n\n\n\n

FULL YEAR 2024<\/strong><\/h2>\n\n\n\n

The Voluntary Framework on Disclosure was developed by Innovative Medicines Canada<\/a>. As a partner in Canada\u2019s health care system, Merck Canada Inc. regularly collaborates with healthcare professionals (HCPs) and healthcare organizations (HCOs) to foster scientific exchange, for the ultimate benefit of patients. These collaborations are bound by local and international laws and regulated by Innovative Medicine Canada\u2019s Code of Ethical Practices<\/a>. The decision of Merck Canada Inc. to publish our payments to HCPs and HCOs is voluntary and part of our overall commitment to greater transparency and high ethical standards in our business practices.<\/p>\n\n\n\n

All payment information has been captured in aggregate form (one sum total) and presented below in three categories. The categories are defined by the Voluntary Framework on Disclosure of Payments<\/a>.<\/p>\n\n\n\n

<\/div>\n\n\n\n